Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis.
- Published in:
- Immunopharmacology & Immunotoxicology, 2014, v. 36, n. 4, p. 282, doi. 10.3109/08923973.2014.931421
- By:
- Publication type:
- Article
Works matching DE "TUMOR necrosis factor converting enzyme"
Results: 16
1
2
Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
- Published in:
- Journal of Cardiothoracic Surgery, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13019-015-0248-3
- By:
- Publication type:
- Article
3
Molecular Descriptors in Modelling the Tumour Necrosis Factor-α Converting Enzyme Inhibition Activity of Novel Tartrate-Based Analogues.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2013, v. 75, n. 1, p. 36, doi. 10.4103/0250-474X.113539
- By:
- Publication type:
- Article
4
TACE/ADAM17 Is Essential for Oligodendrocyte Development and CNS Myelination.
- Published in:
- Journal of Neuroscience, 2014, v. 34, n. 36, p. 11884, doi. 10.1523/JNEUROSCI.1220-14.2014
- By:
- Publication type:
- Article
5
Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
6
Pref-1, a gatekeeper of adipogenesis.
- Published in:
- Frontiers in Endocrinology, 2013, v. 4, p. 1, doi. 10.3389/fendo.2013.00079
- By:
- Publication type:
- Article
7
The human Cathelicidin LL-37 induces MUC5AC mucin production by airway epithelial cells via TACE-TGF-α-EGFR pathway.
- Published in:
- Experimental Lung Research, 2014, v. 40, n. 7, p. 333, doi. 10.3109/01902148.2014.926434
- By:
- Publication type:
- Article
8
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
- Published in:
- Mediators of Inflammation, 2017, p. 1, doi. 10.1155/2017/9673537
- By:
- Publication type:
- Article
9
Low molecular mass natural and synthetic inhibitors of snake venom metalloproteinases.
- Published in:
- Toxin Reviews, 2018, v. 37, n. 1, p. 19, doi. 10.1080/15569543.2017.1309550
- By:
- Publication type:
- Article
10
A biosensor for the activity of the "sheddase" TACE (ADAM17) reveals novel and cell type-specific mechanisms of TACE activation.
- Published in:
- Science Signaling, 2015, v. 8, n. 365, p. 1, doi. 10.1126/scisignal.2005680
- By:
- Publication type:
- Article
11
An alignment-independent 3D-QSAR study on series of hydroxamic acid-based tumor necrosis factor-α converting enzyme inhibitors.
- Published in:
- Journal of Chemometrics, 2016, v. 30, n. 9, p. 537, doi. 10.1002/cem.2817
- By:
- Publication type:
- Article
12
Systemic Overexpression of TNFα-converting Enzyme Does Not Lead to Enhanced Shedding Activity In Vivo.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054412
- By:
- Publication type:
- Article
13
Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor- α converting enzyme as potential therapeutics for hepatitis.
- Published in:
- Journal of Drug Targeting, 2015, v. 23, n. 10, p. 936, doi. 10.3109/1061186X.2015.1043916
- By:
- Publication type:
- Article
14
Synthesis of [<sup>3</sup>H], [<sup>13</sup>C<sub>3</sub>, <sup>15</sup>N], and [<sup>14</sup>C]SCH 900567: an inhibitor of TNF- α (tumor necrosis factor alpha) converting enzyme (TACE).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 11, p. 632, doi. 10.1002/jlcr.3229
- By:
- Publication type:
- Article
15
Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure.
- Published in:
- Experimental & Therapeutic Medicine, 2014, v. 7, n. 2, p. 329, doi. 10.3892/etm.2013.1409
- By:
- Publication type:
- Article
16
Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves' orbitopathy.
- Published in:
- Advances in Clinical & Experimental Medicine, 2018, v. 27, n. 1, p. 99, doi. 10.17219/acem/68991
- By:
- Publication type:
- Article